Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

Novavax Inc

NVAX
7,89
0,00 (0,00%)
07 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
05/3/202523:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202523:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202523:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202523:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202523:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202500:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202500:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202500:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202500:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202500:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202514:01EDGAR2Form 8-K - Current report
27/2/202522:05PRNUSNovavax to Participate in Upcoming March Investor..
27/2/202514:05EDGAR2Form 8-K - Current report
27/2/202514:00PRNUSNovavax Reports Fourth Quarter and Full Year 2024 Financial..
27/2/202513:41EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20/2/202514:00PRNUSNovavax to Host Conference Call to Discuss Fourth Quarter..
06/2/202501:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202501:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/1/202500:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/1/202513:50EDGAR2Form 8-K - Current report
03/1/202523:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202522:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202522:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202522:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202522:02EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
30/12/202423:27EDGAR2Form 8-K - Current report
26/12/202416:31EDGAR2Form 144 - Report of proposed sale of securities
18/12/202423:24EDGAR2Form 8-K - Current report
13/12/202423:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202418:13EDGAR2Form 144 - Report of proposed sale of securities
13/12/202414:00PRNUSNovavax Advances Corporate Growth Strategy Through Sanofi..
10/12/202414:00PRNUSNovavax Initiates Phase 3 Trial for COVID-19-Influenza..
04/12/202412:00EDGAR2Form 8-K - Current report
04/12/202408:00PRNUSNovavax Announces Sale of Czech Republic Manufacturing Site..
15/11/202413:47PRNUSNovavax Announces Grant of Inducement Awards Pursuant to..
13/11/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202414:00PRNUSNovavax to Participate in Jefferies London Healthcare..
12/11/202422:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202417:21EDGAR2Form 8-K - Current report
12/11/202414:04EDGAR2Form 8-K - Current report
12/11/202414:02PRNUSNovavax Reports Third Quarter 2024 Financial Results and..
11/11/202414:30PRNUSU.S. FDA Removes Clinical Hold on Novavax's..
05/11/202423:01EDGAR2Form 8-K - Current report
04/11/202422:30PRNUSNovavax to Host Conference Call to Discuss Third Quarter..
04/11/202412:00PRNUSÅsa Manelius Named Managing Director of Novavax AB Site
16/10/202414:14PRNUSUpdate on Novavax's COVID-19-Influenza Combination and..
16/10/202414:00EDGAR2Form 8-K - Current report
09/10/202413:00PRNUSNovavax's Updated 2024-2025 Nuvaxovid™ COVID-19 Vaccine..
25/9/202414:00PRNUSNovavax Names Dr. Ruxandra Draghia-Akli as New Executive..
18/9/202422:08EDGAR2Form 144 - Report of proposed sale of securities
Apertura: 7,82 Min: 7,60 Max: 7,99
Chiusura: 7,89

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network